| Melissa Gail Dibler, | |
|
5221 N O Connor Blvd Ste 1400, Irving, TX 75039-3754 | |
| (972) 497-2243 | |
| Not Available |
| Full Name | Melissa Gail Dibler |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Critical Care Medicine |
| Location | 5221 N O Connor Blvd Ste 1400, Irving, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225739758 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WC0200X | Registered Nurse - Critical Care Medicine | 898889 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Gail Dibler, 5221 N O Connor Blvd Ste 1400, Irving, TX 75039-3754 Ph: () - | Melissa Gail Dibler, 5221 N O Connor Blvd Ste 1400, Irving, TX 75039-3754 Ph: (972) 497-2243 |
News Archive
Complete Genomics, a third-generation human genome sequencing company, today announced publication of a report in the journal Science describing its proprietary DNA sequencing platform, including analysis of sequence data from three complete human genomes. The consumables cost for these three genomes sequenced on the proof-of-principle genomic DNA nanoarrays ranged from $8,005 for 87x coverage to $1,726 for 45x coverage for the samples described in this report.
Details of an investigational study have emerged after a man died following a fecal microbiate transplant. The events prompted the FDA to set new safety guidelines for the practice.
Scientists led by UCL (University College London) have induced dyscalculia in subjects without the maths learning difficulty for the first time. The study, which finds that the right parietal lobe is responsible for dyscalculia, potentially has implications for diagnosis and management through remedial teaching.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its partner Auxilium Pharmaceuticals, Inc. announced that Pfizer Inc. received notification from the European Medicines Agency that the Marketing and Authorization Application (MAA) for XIAFLEX™ for the treatment of Dupuytren's disease (a debilitating disorder resulting from excessive collagen deposition that causes contractures of the fingers) has completed the validation phase successfully and that the scientific/technical review procedure commenced today.
› Verified 9 days ago
Gwendoline Valah Nyasa, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3115 Helmet St, Irving, TX 75060 Phone: 704-465-1563 | |
Maurlean Kerubo Kwamanga, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 10513 N Macarthur Blvd Apt 2023, Irving, TX 75063 Phone: 432-599-8048 | |
Maekala Williams, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 6225 N State Highway 161 Ste 200, Irving, TX 75038 Phone: 214-687-0001 Fax: 972-518-2100 | |
Matthew Michael Martin, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 6225 N State Highway 161, Suite 200, Irving, TX 75038 Phone: 214-687-0001 Fax: 972-518-2100 | |
Ms. Melanie Palasi, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 5605 N Macarthur Blvd, Ste. 220, Irving, TX 75038 Phone: 972-714-0007 Fax: 972-714-0009 | |
Mujeebat Suleiman, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 801 Lake Carolyn Pkwy Apt 3082, Irving, TX 75039 Phone: 412-983-1774 | |
Lancy Kuruvila, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1408 Shelby Ct, Irving, TX 75061 Phone: 214-718-7050 Fax: 214-441-3079 |